Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Science (New York, N.Y.)|August 7, 2004
Wind-related processes detected by the Spirit Rover at Gusev Crater, MarsR Greeley, S W Squyres, R E Arvidson, et al.Science (New York, N.Y.)|August 7, 2004
Localization and physical properties experiments conducted by Spirit at Gusev CraterR E Arvidson, R C Anderson, P Bartlett, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2026
Five-Year Survival with Tebentafusp in Metastatic Uveal MelanomaS Piperno-Neumann, P Rutkowski, J C Hassel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanomaC N Owen, X Bai, T Quah, et al.Science (New York, N.Y.)|May 23, 2009
Exploration of Victoria crater by the Mars rover OpportunityS W Squyres, A H Knoll, R E Arvidson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinomaL Goyal, D DiToro, F Facchinetti, et al.Science (New York, N.Y.)|December 4, 2004
Pancam multispectral imaging results from the Opportunity Rover at Meridiani PlanumJ F Bell, S W Squyres, R E Arvidson, et al.Science (New York, N.Y.)|August 7, 2004
Pancam multispectral imaging results from the Spirit Rover at Gusev CraterJ F Bell, S W Squyres, R E Arvidson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort studyF Dimitriou, K Namikawa, I L M Reijers, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanomaP Grover, S N Lo, I Li, et al.Pageof 9